Eventide Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

Eventide Asset Management’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-135,000	Closed	-$15.2M	–	163
2023 Q3	$15.2M	Hold	135,000	–	–	0.27%	101
2023 Q2	$12.7M	Hold	135,000	–	–	0.22%	114
2023 Q1	$13.7M	Hold	135,000	–	–	0.25%	108
2022 Q4	$16.1M	Sell	135,000 -100,000	-43%	-$11.9M	0.32%	91
2022 Q3	$25M	Hold	235,000	–	–	0.49%	64
2022 Q2	$22.9M	Hold	235,000	–	–	0.49%	63
2022 Q1	$22M	Hold	235,000	–	–	0.35%	84
2021 Q4	$20M	Hold	235,000	–	–	0.26%	95
2021 Q3	$22.5M	Hold	235,000	–	–	0.3%	87
2021 Q2	$22.9M	Sell	235,000 -239,000	-50%	-$23.3M	0.31%	86
2021 Q1	$46.1M	Buy	474,000 +121,000	+34%	+$11.8M	0.68%	53
2020 Q4	$33.8M	Sell	353,000 -7,200	-2%	-$690K	0.52%	62
2020 Q3	$34.6M	Buy	360,200 +2,400	+0.7%	+$231K	0.68%	51
2020 Q2	$43.7M	Buy	357,800 +4,800	+1%	+$586K	0.95%	37
2020 Q1	$30.6M	Hold	353,000	–	–	0.99%	36
2019 Q4	$37.9M	Hold	353,000	–	–	1.07%	38
2019 Q3	$31.8M	Hold	353,000	–	–	1.05%	33
2019 Q2	$29.8M	Buy	353,000 +83,000	+31%	+$7.01M	0.91%	38
2019 Q1	$23.8M	Buy	270,000 +114,000	+73%	+$10M	0.82%	44
2018 Q4	$11.1M	Hold	156,000	–	–	0.49%	64
2018 Q3	$19.2M	Hold	156,000	–	–	0.7%	50
2018 Q2	$15.3M	Hold	156,000	–	–	0.64%	57
2018 Q1	$12.9M	Hold	156,000	–	–	0.61%	59
2017 Q4	$12.1M	Buy	156,000 +31,000	+25%	+$2.41M	0.63%	56
2017 Q3	$7.66M	Hold	125,000	–	–	0.43%	65
2017 Q2	$5.75M	Hold	125,000	–	–	0.36%	67
2017 Q1	$5.41M	Hold	125,000	–	–	0.36%	71
2016 Q4	$4.84M	Hold	125,000	–	–	0.31%	71
2016 Q3	$6.33M	Hold	125,000	–	–	0.39%	67
2016 Q2	$5.68M	Hold	125,000	–	–	0.35%	70
2016 Q1	$4.94M	Hold	125,000	–	–	0.28%	74
2015 Q4	$7.07M	Sell	125,000 -121,100	-49%	-$6.85M	0.35%	70
2015 Q3	$9.79M	Buy	246,100 +94,700	+63%	+$3.77M	0.57%	54
2015 Q2	$7.23M	Buy	151,400 +13,600	+10%	+$650K	0.39%	63
2015 Q1	$5.47M	Buy	137,800 +25,600	+23%	+$1.02M	0.41%	66
2014 Q4	$2.51M	Buy	112,200 +15,600	+16%	+$349K	0.27%	73
2014 Q3	$1.51M	Hold	96,600	–	–	0.21%	80
2014 Q2	$1.43M	Buy	96,600 +9,300	+11%	+$138K	0.2%	85
2014 Q1	$1.41M	Buy	87,300 +48,800	+127%	+$786K	0.22%	86
2013 Q4	$360K	Buy	+38,500	New	+$360K	0.11%	90